Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine

被引：8

作者：

Pavithran, K ^{[1
]}

Doval, DC ^{[1
]}

机构：

[1] Rajiv Gandhi Canc Inst & Res, New Delhi 110085, India

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2005年 / 28卷 / 02期

关键词：

papillary thyroid carcinoma; I-131; chronic myeloid leukemia; secondary CML;

D O I：

10.1097/01.coc.0000143845.79889.33

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Leukemia as a second malignancy after treatment of thyroid cancer is rare. Most cases reported in the literature-have occurred after cumulative doses higher than 800 mCi and it is most commonly acute leukemias. We report a case of chronic myeloid leukemia (CML) occurring in a 40-year-old man 14 years after treatment of papillary thyroid carcinoma. Our patient had the longest interval between the diagnosis of CML and administration of I-131.

引用

页码：216 / 216

页数：1

共 50 条

[21] THE TREATMENT OF THYROID CARCINOMA WITH RADIOACTIVE IODINE
KAAE, S
PETERSEN, O
ACTA RADIOLOGICA, 1950, 33 (06) : 539 - 556
[22] Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine
Castellanos, Luz E.
Zafereo, Mark E.
Sturgis, Erich M.
Wang, Jennifer R.
Ying, Anita K.
Waguespack, Steven G.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (02): : e208 - e217
[23] Relevance of radioactive iodine therapy in the treatment of mixed anaplastic-papillary thyroid carcinoma
Missaoui, A.
Hamza, F.
Ben Ahmed, K.
Nooman, H.
Maaloul, M.
Chtourou, K.
Guermazi, F.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S670 - S670
[24] Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma
Hay, Ian D.
JOURNAL OF SURGICAL ONCOLOGY, 2006, 94 (08) : 692 - 700
[25] Post-translational Regulation of Radioactive Iodine Therapy Response in Papillary Thyroid Carcinoma
Amit, Moran
Na'ara, Shorook
Francis, Demilza
Matanis, Wisam
Zolotov, Sagit
Eisenhaber, Birgit
Eisenhaber, Frank
Sagie, Michal Weiler
Malkin, Leonid
Billan, Salem
Charas, Tomer
Gil, Ziv
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (12):
[26] Should radioactive iodine therapy be administrated in patient of papillary thyroid carcinoma co-existence with medullary thyroid carcinoma?
Zhao Junyu
Dong Janjun
Sun Qing
Wang Huanjun
Zhang Zhongwen
Zhou Xiaojun
Liao Lin
CHINESE MEDICAL JOURNAL, 2014, 127 (16) : 3039 - 3040
[27] Predictors of radioactive iodine refractoriness in papillary thyroid carcinomas
Masoodi, Tariq
Siraj, Sarah
Siraj, Abdul K.
Azam, Saud
Qadri, Zeeshan
Parvathareddy, Sandeep K.
Al-Kuraya, Khawla S.
CANCER RESEARCH, 2022, 82 (12)
[28] Should radioactive iodine therapy be administrated in patient of papillary thyroid carcinoma co-existence with medullary thyroid carcinoma?
Zhao Junyu
Dong Jianjun
Sun Qing
Wang Huanjun
Zhang Zhongwen
Zhou Xiaojun
Liao Lin
中华医学杂志（英文版）, 2014, (16) : 3039 - 3040
[29] Assessment of different markers of ovarian reserve in women with papillary thyroid cancer treated with radioactive iodine
Adamska, Agnieszka
Tomczuk-Bobik, Paulina
Poplawska-Kita, Anna Beata
Siewko, Katarzyna
Buczynska, Angelika
Szumowski, Piotr
Zukowski, Lukasz
Mysliwiec, Janusz
Zbucka-Kretowska, Monika
Adamski, Marcin
Kretowski, Adam Jacek
ENDOCRINE CONNECTIONS, 2021, 10 (10) : 1283 - 1290
[30] Changes in Gut Microbiota and Metabolites in Papillary Thyroid Carcinoma Patients Following Radioactive Iodine Therapy
Li, Wanting
Cheng, Feng
Zhang, Jun
Li, Caihong
Yu, Daijing
Simayijiang, Halimureti
Liu, Haiyan
Li, Sijin
Yan, Jiangwei
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 4453 - 4464

← 1 2 3 4 5 →